Our previous work identified GPER1 as a key mediator of tamoxifen action in breast cancer cells (Vaziri-Gohar & Houston 2016) leading to the hypothesis that GPER1 expression is sensitive to [D-glucose] and changes in GPER1 expression alters the tamoxifen response in breast cancer cells. Here, GPER1 is linked to breast carcinoma.